tiprankstipranks
Trending News
More News >
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
US Market
Advertisement

Aclaris Therapeutics (ACRS) Technical Analysis

Compare
791 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Aclaris Therapeutics’s (ACRS) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Aclaris Therapeutics is a Sell.
Aclaris Therapeutics’s (ACRS) 20-Day exponential moving average is 1.69, while Aclaris Therapeutics’s (ACRS) share price is $1.75, making it a Buy.
Aclaris Therapeutics’s (ACRS) 50-Day exponential moving average is 1.60, while Aclaris Therapeutics’s (ACRS) share price is $1.75, making it a Buy.

Aclaris Therapeutics (ACRS) Pivot Points

Aug 23, 2025, 05:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.70
1.74
1.77
1.81
1.84
1.88
1.91
Fibonacci
1.74
1.76
1.78
1.81
1.83
1.85
1.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aclaris Therapeutics (ACRS) Moving Averages

Aug 23, 2025, 05:16 PM
Period
Simple
Exponential
MA5
1.81Sell
1.78Sell
MA10
1.74Buy
1.74Buy
MA20
1.66Buy
1.69Buy
MA50
1.58Buy
1.60Buy
MA100
1.45Buy
1.60Buy
MA200
2.00Sell
1.79Sell
Aclaris Therapeutics’s (ACRS) 10-Day exponential moving average is 1.74, while Aclaris Therapeutics’s (ACRS) share price is $1.75, making it a Buy.
Aclaris Therapeutics’s (ACRS) 100-Day exponential moving average is 1.60, while Aclaris Therapeutics’s (ACRS) share price is $1.75, making it a Buy.
Aclaris Therapeutics’s (ACRS) stock price is $1.75 and Aclaris Therapeutics’s (ACRS) 50-day simple moving average is 1.58, creating a Buy signal.
Aclaris Therapeutics’s (ACRS) stock price is $1.75 and Aclaris Therapeutics’s (ACRS) 100-day simple moving average is 1.45, creating a Buy signal.
Aclaris Therapeutics’s (ACRS) stock price is $1.75 and Aclaris Therapeutics’s (ACRS) 200-day simple moving average is 2.00, creating a Sell signal.

Aclaris Therapeutics (ACRS) Technical Indicators

Aug 23, 2025, 05:16 PM
Name
Value
Implied Action
RSI (14)
58.84
Neutral
STOCH (9,6)
62.02
Neutral
STOCHRSI (14)
68.36
Neutral
MACD (12,26)
0.07
Sell
ADX (14)
46.07
Neutral
Williams %R
-40.48
Buy
CCI (14)
83.40
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
51.57
Neutral
ROC
14.38
Buy
Aclaris Therapeutics’s (ACRS) Relative Strength Index (RSI) is 58.84, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Trend Strength Indicator (ADX) is 46.07, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Commodity Channel Index (CCI) is 83.40, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Price Rate of Change (ROC) is 14.38, creating a Buy signal.

FAQ

Is ACRS a Buy, Hold, or Sell?
Based on ACRS’s technical indicators, ACRS is a Buy.
    What is ACRS’s RSI (14)?
    ACRS’s RSI (14) is 58.84, which suggests ACRS is a Neutral.
      What is ACRS’s MACD?
      ACRS’s MACD is 0.07, which suggests ACRS is a Sell.
        What is ACRS’s 5-day moving average?
        ACRS’s 5-day moving average is 1.81, which suggests ACRS is a Sell.
          What is ACRS’s 20-day moving average?
          ACRS 20-day moving average is 1.66, which suggests ACRS is a Buy.
            What is ACRS’s 50-day moving average?
            ACRS’s 50-day moving average is 1.58, which suggests ACRS is a Buy.
              What is ACRS’s 200-day moving average?
              ACRS’s 200-day moving average is 2.00, which suggests ACRS is a Sell.
                What is ACRS’s Williams % R (14)?
                ACRS’s Williams % R (14) is -40.48, which suggests ACRS is a Buy.
                  What is ACRS’s CCI (14)?
                  ACRS’s CCI (14) is 83.40, which suggests ACRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis